carnosine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ignacio, S; Lee, NM; Moore, DH; Smith, AP | 1 |
| Eum, WS; Kang, JH | 1 |
2 other study(ies) available for carnosine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Carnosine; Disease Models, Animal; Drug Evaluation, Preclinical; Flavanones; Gene Expression; Gene Expression Regulation; Genetic Markers; Inflammation; Metallothionein; Mice; Mice, Knockout; Neuroprotective Agents; Neurotoxins; Oxidative Stress; RNA; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2005 |
Enhanced oxidative damage by the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants.
Topics: Amyotrophic Lateral Sclerosis; Carnosine; Copper; DNA Damage; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Escherichia coli; Free Radical Scavengers; Free Radicals; Humans; Hydrogen Peroxide; Lipid Peroxidation; Mutation; Oxidative Stress; Plasmids; Recombinant Proteins; Superoxide Dismutase | 2000 |